After finishing at $0.88 in the prior trading day, Altamira Therapeutics Ltd. (NASDAQ: CYTO) closed at $0.82, down -6.67%. In other words, the price has decreased by -$0.0586 from its previous closing price. On the day, 1385053 shares were traded. CYTO stock price reached its highest trading level at $0.8500 during the session, while it also had its lowest trading level at $0.8000.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Our goal is to gain a better understanding of CYTO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.20 and its Current Ratio is at 0.20. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYTO now has a Market Capitalization of 6.08M and an Enterprise Value of 13.10M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 0.07. Its current Enterprise Value per Revenue stands at 42.86 whereas that against EBITDA is -0.51.
Stock Price History:
Over the past 52 weeks, CYTO has reached a high of $18.40, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is 1.1747, while the 200-Day Moving Average is calculated to be 4.3341.
The stock has traded on average 2.82M shares per day over the past 3-months and 1.6M shares per day over the last 10 days, according to various share statistics. A total of 6.99M shares are outstanding, with a floating share count of 6.91M. Insiders hold about 7.10% of the company’s shares, while institutions hold 1.90% stake in the company. Shares short for CYTO as of May 14, 2023 were 86.07k with a Short Ratio of 0.09M, compared to 1.2M on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.23% and a Short% of Float of 1.23%.
Its stock is currently analyzed by 0 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.